Literature DB >> 27708278

Neurohormonal activation in heart failure with reduced ejection fraction.

Justin Hartupee1, Douglas L Mann1.   

Abstract

Heart failure with reduced ejection fraction (HFrEF) develops when cardiac output falls as a result of cardiac injury. The most well-recognized of the compensatory homeostatic responses to a fall in cardiac output are activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS). In the short term, these 'neurohormonal' systems induce a number of changes in the heart, kidneys, and vasculature that are designed to maintain cardiovascular homeostasis. However, with chronic activation, these responses result in haemodynamic stress and exert deleterious effects on the heart and the circulation. Neurohormonal activation is now known to be one of the most important mechanisms underlying the progression of heart failure, and therapeutic antagonism of neurohormonal systems has become the cornerstone of contemporary pharmacotherapy for heart failure. In this Review, we discuss the effects of neurohormonal activation in HFrEF and highlight the mechanisms by which these systems contribute to disease progression.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27708278      PMCID: PMC5286912          DOI: 10.1038/nrcardio.2016.163

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  103 in total

1.  PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.

Authors:  S O Marx; S Reiken; Y Hisamatsu; T Jayaraman; D Burkhoff; N Rosemblit; A R Marks
Journal:  Cell       Date:  2000-05-12       Impact factor: 41.582

2.  Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators.

Authors:  F Zannad; F Alla; B Dousset; A Perez; B Pitt
Journal:  Circulation       Date:  2000-11-28       Impact factor: 29.690

3.  Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease.

Authors:  C G Brilla; R C Funck; H Rupp
Journal:  Circulation       Date:  2000-09-19       Impact factor: 29.690

4.  Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.

Authors:  M R Bristow; R Ginsburg; V Umans; M Fowler; W Minobe; R Rasmussen; P Zera; R Menlove; P Shah; S Jamieson
Journal:  Circ Res       Date:  1986-09       Impact factor: 17.367

5.  Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study.

Authors:  Hideo Izawa; Toyoaki Murohara; Kohzo Nagata; Satoshi Isobe; Hiroyuki Asano; Tetsuya Amano; Sahoko Ichihara; Tomoko Kato; Satoru Ohshima; Yosuke Murase; Shigeo Iino; Koji Obata; Akiko Noda; Kenji Okumura; Mitsuhiro Yokota
Journal:  Circulation       Date:  2005-11-08       Impact factor: 29.690

6.  Angiotensin IV activates the nuclear transcription factor-kappaB and related proinflammatory genes in vascular smooth muscle cells.

Authors:  Vanesa Esteban; Mónica Ruperez; Elsa Sánchez-López; Juan Rodríguez-Vita; Oscar Lorenzo; Heidi Demaegdt; Patrick Vanderheyden; Jesús Egido; Marta Ruiz-Ortega
Journal:  Circ Res       Date:  2005-04-14       Impact factor: 17.367

7.  Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure.

Authors:  J W Adams; Y Sakata; M G Davis; V P Sah; Y Wang; S B Liggett; K R Chien; J H Brown; G W Dorn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

8.  The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure.

Authors:  M Packer
Journal:  J Am Coll Cardiol       Date:  1992-07       Impact factor: 24.094

Review 9.  Pathophysiology of water and sodium retention: edematous states with normal kidney function.

Authors:  Mir Reza Bekheirnia; Robert William Schrier
Journal:  Curr Opin Pharmacol       Date:  2006-02-17       Impact factor: 5.547

Review 10.  Adrenergic nervous system in heart failure: pathophysiology and therapy.

Authors:  Anastasios Lymperopoulos; Giuseppe Rengo; Walter J Koch
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

View more
  109 in total

1.  Qiliqiangxin attenuates isoproterenol-induced cardiac remodeling in mice.

Authors:  Jialiang Zhang; Mengyuan Huang; Shutong Shen; Xiaoting Wu; Xiaodong Wu; Ping Lv; Haifeng Zhang; Hui Wang; Xinli Li
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

Review 2.  Improving Provider Adherence to Guideline Recommendations in Heart Failure.

Authors:  Katherine E Di Palo; Ileana L Piña; Hector O Ventura
Journal:  Curr Heart Fail Rep       Date:  2018-12

3.  Angiotensin-converting-enzyme inhibitors in hemodynamic congestion: a meta-analysis of early studies.

Authors:  Alexander Jobs; Amr Abdin; Suzanne de Waha-Thiele; Ingo Eitel; Holger Thiele; Cor de Wit; Reinhard Vonthein
Journal:  Clin Res Cardiol       Date:  2019-03-20       Impact factor: 5.460

4.  Renal Denervation to Treat Heart Failure.

Authors:  Thomas E Sharp; David J Lefer
Journal:  Annu Rev Physiol       Date:  2020-10-19       Impact factor: 19.318

5.  The Impact of Hemodynamic Reflex Compensation Following Myocardial Infarction on Subsequent Ventricular Remodeling.

Authors:  Colleen Witzenburg; Jeffrey W Holmes
Journal:  J Biomech Eng       Date:  2019-05-29       Impact factor: 2.097

6.  Relationship between non-osmotic arginine vasopressin secretion and hemoglobin A1c levels in adult patients with congenital heart disease.

Authors:  Tomoaki Murakami; Yoko Horibata; Shigeru Tateno; Yasutaka Kawasoe; Koichiro Niwa
Journal:  Heart Vessels       Date:  2018-11-20       Impact factor: 2.037

Review 7.  Targeting Mitochondrial Calcium Handling and Reactive Oxygen Species in Heart Failure.

Authors:  Alexander Dietl; Christoph Maack
Journal:  Curr Heart Fail Rep       Date:  2017-08

Review 8.  β-Adrenoceptor activation affects galectin-3 as a biomarker and therapeutic target in heart disease.

Authors:  Xiao-Jun Du; Wei-Bo Zhao; My-Nhan Nguyen; Qun Lu; Helen Kiriazis
Journal:  Br J Pharmacol       Date:  2019-04-07       Impact factor: 8.739

Review 9.  Anticoagulation in atrial fibrillation with heart failure.

Authors:  Lei Zhao; William Y S Wang; Xinchun Yang
Journal:  Heart Fail Rev       Date:  2018-07       Impact factor: 4.214

10.  Pediatric and adult dilated cardiomyopathy represent distinct pathological entities.

Authors:  Meghna D Patel; Jayaram Mohan; Caralin Schneider; Geetika Bajpai; Enkhsaikhan Purevjav; Charles E Canter; Jeffrey Towbin; Andrea Bredemeyer; Kory J Lavine
Journal:  JCI Insight       Date:  2017-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.